Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade-and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-jB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.
Ovarian cancer Sympathetic nervous system Gene expression Transcription factor Beta-adrenergic receptor a b s t r a c t Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade-and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-jB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.
Ó 2008 Elsevier Inc. All rights reserved.
Introduction
Biobehavioral factors such as stress, depression, and social support have long been suspected to influence cancer onset and disease progression, but the molecular mechanisms of these effects are just beginning to be elucidated (Antoni et al., 2006) . Recent findings from laboratory models suggest that biobehavioral processes can influence cancer biology via direct effects of the neuroendocrine system on the functional activity of tumor cells (Thaker et al., 2006) . Many solid epithelial tumors express receptors for neuroendocrine mediators from the sympathetic nervous system (SNS) (the catecholamines, epinephrine and norepinephrine) (Mitra and Carraway, 1999; Lutgendorf et al., 2003; Nagmani et al., 2003; Palm et al., 2006; Thaker et al., 2006; Ramos-Jimenez et al., 2007; Sastry et al., 2007) or the hypothalamus-pituitaryadrenal (HPA) axis (the glucocorticoid, cortisol) (Wu et al., 2004) . Analyses carried out in vitro and in mouse xenograft models have shown that neuroendocrine receptors can regulate several biological processes involved in cancer metastasis and disease progression, including angiogenesis (Lutgendorf et al., 2003; Thaker et al., 2006) , tissue invasion (Sood et al., 2006; Yang et al., 2006) , cell motility (Palm et al., 2006) , and programmed cell death (Wu et al., 2004; Sastry et al., 2007) . Analyses of mouse xenograft models also show that experimentally imposed behavioral stress can increase the growth and metastatic activity of implanted human 
